Tags: anemiamyelofibrosissplenomegalybacterial infectionjanus
Profile | Contacts | Recent Articles on Subject | |
---|---|---|---|
1 | Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts | ||
2 | Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA | Evaluating New Data for Transplant-Eligible Patients With NDMM: PERSEUS, IsKia, and GMMG HD7 - 18 days ago Real-World Considerations for New Therapies - 25 days ago Impact of Transplant Eligibility on Treatment Selection - about 1 month ago | |
3 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | Advances in CAR T-Cell Therapy and Bispecifics for Relapsed/Refractory Multiple Myeloma - 19 days ago | |
4 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | Real World CAR T-Cell Therapy Outcomes 'Favorable' in Relapsed/Refractory Myeloma - about 1 month ago All-Oral Therapy Promising in Higher-Risk MDS, CMML - 9 months ago How a Multi-Cancer Screening Test Would Play Out in the Clinic - about 1 year ago | |
5 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | ||
6 | John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. | Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus - 2 months ago | |
7 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | ||
8 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 4 months ago Why Some Myeloma Patients Refuse Stem Cell Transplant - 11 months ago | |
9 | Ian Ingram MedPage Today Deputy Managing Editor.
MedPage Today. New York, New York | FDA Approves Earlier Use of CAR-T Products for Myeloma - 7 months ago | |
10 | Judy George MedPage Today Medical reporter, writer. |